Efficacy of Rituximab in a Systemic Lupus Erythematosus Patient Presenting with Diffuse Alveolar Hemorrhage
Diffuse alveolar hemorrhage (DAH) is a life-threatening complication of systemic lupus erythematosus (SLE). Although infrequent, its mortality is very high. While there are no established therapeutic guidelines, DAH has been traditionally managed with high-dose intravenous (IV) corticosteroids, cycl...
Saved in:
Main Authors: | Gabriela Montes-Rivera, Grissel Ríos, Luis M. Vilá |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2017-01-01
|
Series: | Case Reports in Rheumatology |
Online Access: | http://dx.doi.org/10.1155/2017/6031053 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Systemic Lupus Erythematosus Presenting with Alveolar Hemorrhage
by: Omar Tolaymat, et al.
Published: (2018-01-01) -
Diffuse Alveolar Hemorrhage in Patients with Systemic Lupus Erythematosus: A Single Center Retrospective Study in Malaysia
by: Piem Jie Leong, et al.
Published: (2024-12-01) -
A Fatal Case of Diffuse Alveolar Hemorrhage in the Setting of Systemic Lupus Erythematosus: A Case Report and Review of Noninfectious Causes of Acute Pulmonary Hemorrhage in Adults
by: Mia C. Lundgren, et al.
Published: (2021-01-01) -
Diffuse Alveolar Hemorrhage Induced by Vaping
by: Michael Agustin, et al.
Published: (2018-01-01) -
Guillain–barre syndrome as a presenting feature of systemic lupus erythematosus in a child and it's complete resolution with rituximab treatment
by: Rahul Reddy, et al.
Published: (2019-01-01)